Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD)
Clinical trial NCT06391450 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06391450
- Sponsor
- Hannover Medical School
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2027-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.